People · Operator
Named in public records as an officer, director or promoter · active 2012–2019 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Liquipel Worldwide Holdings, LLC | — | Other Technology | Series A | $15.5M | $152.6M | 2012 |
| Instaprotek, Llc | — | Other Technology | Pre-Seed | $1.0M | $42.4M | 2019 |
| Actimis Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $452K | $21.4M | 2017 |
Kevin Bacon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Bacon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marvin Winkler | 2 | 4 |
| Vafa Rakshani | 2 | 2 |
| Scott Johnson | 1 | 10 |
| Peter McWilliams | 1 | 2 |
| Fred Middleton | 1 | 2 |
| Brian Manahan | 1 | 1 |
| Daniel McPhail | 1 | 1 |
| Samuel Winkler | 1 | 1 |
| James Valentine | 1 | 1 |
| Masaji Matsuoka | 1 | 1 |
| Sam Winkler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.